JP2024538097A - Trem組成物及び使用方法 - Google Patents

Trem組成物及び使用方法 Download PDF

Info

Publication number
JP2024538097A
JP2024538097A JP2024522280A JP2024522280A JP2024538097A JP 2024538097 A JP2024538097 A JP 2024538097A JP 2024522280 A JP2024522280 A JP 2024522280A JP 2024522280 A JP2024522280 A JP 2024522280A JP 2024538097 A JP2024538097 A JP 2024538097A
Authority
JP
Japan
Prior art keywords
trem
modification
domain
natural
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024522280A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024538097A5 (cg-RX-API-DMAC7.html
Inventor
テオニー アナスタシアディス,
デイビッド チャールズ ドネール バトラー,
ニール クビサ,
チンイー リー,
ニコライ ナルイシュキン,
ウェティー, アルマンド ガティアン エンガーヌー
スティーブン ウィリアム アイクホルン,
ウィリアム エフ. キースマン,
クリストファー イー. アルカディア,
ホンチュアン ユー,
Original Assignee
フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー filed Critical フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー
Publication of JP2024538097A publication Critical patent/JP2024538097A/ja
Publication of JP2024538097A5 publication Critical patent/JP2024538097A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/531—Stem-loop; Hairpin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP2024522280A 2021-10-13 2022-10-13 Trem組成物及び使用方法 Pending JP2024538097A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202163255426P 2021-10-13 2021-10-13
US202163255420P 2021-10-13 2021-10-13
US63/255,426 2021-10-13
US63/255,420 2021-10-13
US202163284946P 2021-12-01 2021-12-01
US202163284934P 2021-12-01 2021-12-01
US63/284,934 2021-12-01
US63/284,946 2021-12-01
PCT/US2022/046632 WO2023064513A2 (en) 2021-10-13 2022-10-13 Trem compositions and methods of use

Publications (2)

Publication Number Publication Date
JP2024538097A true JP2024538097A (ja) 2024-10-18
JP2024538097A5 JP2024538097A5 (cg-RX-API-DMAC7.html) 2025-10-22

Family

ID=85987785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024522280A Pending JP2024538097A (ja) 2021-10-13 2022-10-13 Trem組成物及び使用方法

Country Status (11)

Country Link
US (1) US20240401047A1 (cg-RX-API-DMAC7.html)
EP (1) EP4416288A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024538097A (cg-RX-API-DMAC7.html)
KR (1) KR20240107319A (cg-RX-API-DMAC7.html)
CN (1) CN120418430A (cg-RX-API-DMAC7.html)
AU (1) AU2022362286A1 (cg-RX-API-DMAC7.html)
CA (1) CA3235264A1 (cg-RX-API-DMAC7.html)
IL (1) IL311867A (cg-RX-API-DMAC7.html)
MX (1) MX2024004568A (cg-RX-API-DMAC7.html)
TW (1) TW202325313A (cg-RX-API-DMAC7.html)
WO (1) WO2023064513A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025080866A1 (en) * 2023-10-10 2025-04-17 Hc Bioscience, Inc. Trna therapeutics for hemophilia
CN117805381B (zh) * 2024-02-29 2024-05-28 首都医科大学附属北京积水潭医院 检测Gasdermin蛋白家族的物质在制备检测骨肉瘤的产品中的应用
WO2026073261A1 (en) * 2024-09-30 2026-04-02 Flagship Pioneering Innovations Vi, Llc Lipid nanoparticle formulations of trems
WO2026080471A2 (en) * 2024-10-07 2026-04-16 Flagship Pioneering Innovations Vi, Llc Compositions of trem conjugates and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5679147B2 (ja) * 2008-02-07 2015-03-04 独立行政法人理化学研究所 非天然塩基を含む改変tRNA及びその用途
WO2020069194A1 (en) * 2018-09-26 2020-04-02 Case Western Reserve University Methods and compositions for treating a premature stop codon-mediated disorder
JP2022534988A (ja) * 2019-05-31 2022-08-04 フラッグシップ パイオニアリング, インコーポレイテッド tRNAプールを調節するためのTREMの使用
JP7712270B2 (ja) * 2019-11-01 2025-07-23 テバード バイオサイエンシズ インコーポレイテッド 未成熟終止コドン媒介障害を処置するための方法および組成物
WO2021142343A1 (en) * 2020-01-09 2021-07-15 The Regents Of The University Of California Targeting transfer rna for the suppression of nonsense mutations in messenger rna
BR112022020780A2 (pt) * 2020-04-14 2022-11-29 Flagship Pioneering Innovations Vi Llc Composições de trem e usos das mesmas
US20230203510A1 (en) * 2020-05-29 2023-06-29 Flagship Pioneering Innovations Vi, Llc Trem compositions and methods relating thereto
KR20230135585A (ko) * 2020-12-23 2023-09-25 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 변형된 trem의 조성물 및 이의 용도

Also Published As

Publication number Publication date
US20240401047A1 (en) 2024-12-05
AU2022362286A1 (en) 2024-05-02
TW202325313A (zh) 2023-07-01
MX2024004568A (es) 2024-06-28
WO2023064513A9 (en) 2024-08-02
WO2023064513A3 (en) 2023-06-15
KR20240107319A (ko) 2024-07-09
CN120418430A (zh) 2025-08-01
WO2023064513A2 (en) 2023-04-20
EP4416288A2 (en) 2024-08-21
IL311867A (en) 2024-06-01
CA3235264A1 (en) 2023-04-20

Similar Documents

Publication Publication Date Title
US10731159B2 (en) Cationic lipid
JP7174109B2 (ja) 腫瘍溶解性ウイルスベクター及びその使用
US12121531B2 (en) TREM compositions and uses thereof
WO2018232355A1 (en) Rna antibodies
TW200526624A (en) Cyclic aryl derivatives containing with heteroaryl ring
BR112019020175A2 (pt) Derivados de indolina substituídos como inibidores da replicação viral da dengue
JP2008208139A (ja) 4環縮合複素環化合物及びそのhcvポリメラーゼ阻害剤としての利用
JP2024528540A (ja) 遺伝子操作されたガイドrna及びポリヌクレオチド
JP2023527413A (ja) Trem組成物及びそれに関連する方法
WO2023064513A9 (en) Trem compositions and methods of use
UA125644C2 (uk) ЗАМІЩЕНІ 5,6,7,8-ТЕТРАГІДРО[1,2,4]ТРИАЗОЛО[4,3-а]ПІРИДИН-3(2Н)-ОНИ ТА 2,5,6,7-ТЕТРАГІДРО-3Н-ПІРОЛО[2,1-с][1,2,4]ТРИАЗОЛ-3-ОНИ ТА ЇХ ЗАСТОСУВАННЯ
TW202334425A (zh) 一種dsrna、其製備方法及應用
TW202340463A (zh) 調節補體因子b之組合物及其使用方法
FR2763845A1 (fr) Produits anti-cancereux pour le traitement de la mucoviscidose
EP1549351A1 (en) Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis
TW202322825A (zh) 前微血管增滲素調節組合物及其使用方法
TWI318202B (en) Oligo acid derivatives
AU2024255972A1 (en) Modified trems, compositions, and related methods thereof
JP2026514001A (ja) Trem組成物及びその使用方法
US20090162349A1 (en) Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels

Legal Events

Date Code Title Description
A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20240830

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251014

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251014